We're learning more about the hundreds of Internet sites that advertise or sell controlled medications by mail. Yet a new set of answers brings a series of worrisome questions: How many of these websites actually require a prescription for controlled substances? Do many of those who buy prescription drugs online do so with nefarious intentions? Dr. Charles Turck probes problematic developments in online drug sales with Susan Foster, vice president and director of policy research and analysis at the National Center on Addiction and Substance Abuse at Columbia University. Ms. Foster directed the preparation of the Center's most recent You've Got Drugs report on spurious drug sales on the Internet.
Troubling Trends in Online Prescription Drug Sales
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
We're learning more about the hundreds of Internet sites that advertise or sell controlled medications by mail. Yet a new set of answers brings a series of worrisome questions: How many of these websites actually require a prescription for controlled substances? Do many of those who buy prescription drugs online do so with nefarious intentions? Dr. Charles Turck probes problematic developments in online drug sales with Susan Foster, vice president and director of policy research and analysis at the National Center on Addiction and Substance Abuse at Columbia University. Ms. Foster directed the preparation of the Center's most recent You've Got Drugs report on spurious drug sales on the Internet.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
FCS and SHTG: Are We Meeting the Need?
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
HF Management for Patients with Comorbid Conditions
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
NYHA FC and Finerenone Response: Clinical Trial Insights
Semaglutide improves walking distance, symptoms and QoL in patients with PAD and T2D
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?